Cargando…
Biomarkers for Stroke
BACKGROUND: Major stroke clinical trials have failed during the past decades. The failures suggest the presence of heterogeneity among stroke patients. Biomarkers refer to indicators found in the blood, other body fluids or tissues that predicts physiologic or disease states, increased disease risk,...
Autores principales: | Kim, Suk Jae, Moon, Gyeong Joon, Bang, Oh Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Stroke Society
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779673/ https://www.ncbi.nlm.nih.gov/pubmed/24324937 http://dx.doi.org/10.5853/jos.2013.15.1.27 |
Ejemplares similares
-
Adult Stem Cell Therapy for Stroke: Challenges and Progress
por: Bang, Oh Young, et al.
Publicado: (2016) -
Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial
por: Kim, Suk Jae, et al.
Publicado: (2013) -
Cancer-Related Stroke: An Emerging Subtype of Ischemic Stroke with Unique Pathomechanisms
por: Bang, Oh Young, et al.
Publicado: (2020) -
The determinants of stroke phenotypes were different from the predictors (CHADS(2 )and CHA(2)DS(2)-VASc) of stroke in patients with atrial fibrillation: a comprehensive approach
por: Oh, Semi, et al.
Publicado: (2011) -
Ischemic Stroke and Cancer: Stroke Severely Impacts Cancer Patients, While Cancer Increases the Number of Strokes
por: Bang, Oh Young, et al.
Publicado: (2011)